INDV Indivior
- 11.660
- +0.120+1.04%
- 11.660
- 0.0000.00%
Indivior News
Jefferies Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $24.41
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Indivior (INDV)
Indivior CFO to Step Down From Board Following Discussions With Oaktree Capital
Indivior PLC Restructures Board to Enhance Shareholder Value
Indivior (LON:INDV) Shareholder Returns Have Been Enviable, Earning 366% in 5 Years
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $16
Indivior Management to Meet Virtually With Northland
Indivior to Engage With Investors at Healthcare Conference
Indivior Shares Sublocade Trial Findings at CSAM Conference
Indivior Data Shows Rapid Initiation With Once-Monthly SUBLOCADE Significantly Improves Retention In Opioid Use Disorder Patients, Especially Among Fentanyl-Positive Participants; Study Also Administered Second SUBLOCADE Injection A Week Later Vs....
Indivior PLC Executes Strategic Share Repurchase
Indivior's Voting Rights Shift With Madison Avenue
US Manufacturing Index Rises To 43, Highest Since 2020
Indivior Extends Board Tenure Amidst Shareholder Changes
Deerfield's Strategic Stake Acquisition in Indivior
M&A Deals Roundup: Blackstone, BCE, CrowdStrike, Danone and More
Indivior Shareholder Oaktree Capital Calls for Board Refresh
Indivior Engages With Oaktree on Value Proposals
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior
No Data